Human Metapneumovirus Immunization

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Human Metapneumovirus Immunization trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06984094

First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

This phase 1 study will evaluate the safety, reactogenicity, and immunogenicity of 3 different dose levels of SCB-1022 and SCB-1033 in healthy adults aged 60-85…

Australia192 participantsStarted 2025-06-18

Treatment: SCB-1019T, SCB-1022

All recent trials (3 shown)

CompletedPhase 1

NCT06850051

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainflue…

The objective of this study is to evaluate the safety and immunogenicity of different vaccines of hemagglutinin formulations of trivalent influenza vaccine or o…

Australia270 participantsStarted 2025-03-19

Treatment: TIV-HA Vaccine formulation 1 at low dose, TIV-HA formulation 1 at high dose

Active — Not RecruitingPhase 1/2

NCT06686654

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle…

The aim of this study is to evaluate the safety and immunogenicity of a human metapneumovirus (hMPV) / respiratory syncytial virus (RSV) mRNA vaccine candidate…

United States1,530 participantsStarted 2024-11-11

Treatment: